20 LATEST RESOURCES (247 INDEXED)
Ketamine for Adults with Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update · January 2024
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Early Intervention Programs for Adolescents and Young Adults with Eating Disorders · December 2023
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Telephone Triage Services · September 2023
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Emergency Care Follow-Up for Children and Adolescents with Suicide Attempts or Ideation · July 2023
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Deep Brain Stimulation Surgery Programs in Canada · June 2023
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Evidence Base for Virtual Primary Care · May 2023
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Occupational Therapy for Mental Health Conditions and Substance Use Disorders · April 2023
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Nabilone for the Treatment of Post-Traumatic Stress Disorder: A 2023 Update · February 2023
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Peer Support Programs for Youth Mental Health · November 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Intravenous Iron Preparations for Patients Undergoing Elective Surgery: A 2022 Update · October 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Intravenous Iron Isomaltoside for Patients with Iron Deficiency Undergoing Elective Surgery · October 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Treatment Strategies for Sexual Dysfunction Associated With Psychotropic Medications · September 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Internet-Delivered Cognitive Behavioural Therapy in the Treatment of Chronic Non-Cancer Pain · September 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Cannabis for Opioid Use Disorder · September 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Virtual Care Use in Primary Care or Specialty Care Settings · August 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder · July 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Utilization of Cholinesterase Inhibitors for Alzheimer’s Disease in Canada · June 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Melatonin for the Treatment of Insomnia in Children and Adolescents · June 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Monitoring Patients with Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy · June 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Stepped Care Models for Chronic Pain · May 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health